Choice of Treatment Method for Patients With Sliding Hernia of the Esophageal Orifice of the Diaphragm Reflux Esophagitis
Abstract
Reflux esophagitis (synonyms: gastroesophageal reflux disease, GERD) is a disease associated with a violation of the closure function of the lower esophageal sphincter (NPS) and the prolonged effect of stomach contents on the mucous membrane of the esophagus [1].
References
Bilharts L.I. Complications of gastroesophageal reflux disease. //Russian Journal. Gastroenterol. hepatol. – 1998. - No. 5. – pp. 69-76.
Champault G., Voltaire F., Rizc N. Et.al . Gastroesophageal reflux: Conventional Surgical Treatment Versus Laparosc. //Eur J Coelio-Surg. 1997. No. 2– pp. 32-38.
Grinevich V. B. Gastroesophageal reflux disease and its extraesophageal manifestations: modern concepts of diagnosis and treatment / V. B. Grinevich, O. A. Sablin. – St. Petersburg. Beresta, 2004. 170 p.
Starostin B. D. Optimization of treatment of gastroesophageal reflux disease / B. D. Starostin // Russian Journal. hepatology, gastroenterology, coloproctology. - 2007. – Vol. 17, No. 4. – pp. 4-10.
Lukina A. S. Barrett's esophagus / A. S. Lukina // Klin. endoscopy. – 2008. – No. 1. – pp. 42-48.
Fraser-Moodie C.A, Norton B., Gornall C., Magnago S., Weale A.R., Holmes G.K. Weight loss has an independent beneficial effect on symptoms of gastroesophageal reflex in patients who are overweight. Scand J Gastroenterol. 1999;34:337-40.
Singh M., Lee J., Gupta N., Gaddam S., Smith B.K., Wani S.B. et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring). 2013;21: 284-90.
Pantoflickova D., Dorta G., Ravic M., Jornod P., Blum A.L. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Aliment Pharmacol Ther. 2003;17:1507-14.
Shklyaev A.E., Dudarev M.V. GASTROESOPHAGEAL REFLUX DISEASE: DIAGNOSIS, DRUG TREATMENT, BALNEOTHERAPY.
Zimmerman Ya.S., Vologzhanina L.G. Gastroesophageal reflux disease: current state of the problem and prospects. Wedge. honey. 2016; 94 (7): 485-496.
Lazebnik L.B., Masharova A.A., Bordin D.S., and others. The results of the multicenter study "Epidemiology of gastroesophageal reflux disease in Russia" (MAGRE). Therapeutic Archive. 2011; 83 (1): 45-50.
Julai G.S., Sekareva E.V. Secretory and motor evacuation activity of the stomach and duodenum in patients with GERD associated with different types of reflux. Therapeutic Archive. 2016; 88 (2): 16-20.
Kaibysheva V.O., Storonova O.A., Trukhmanov A.S., Ivashkin V.T. Intraesophageal pH-impedance measurement in the diagnosis of GERD. Russian Journal of Gastroenterology, Hepatology, and Coloproctology. 2013; (2): 4-12.
Korepanov A.M., Mikhailova M.D. The use of spa factors in the treatment of gastroesophageal reflux disease. Issues of balneology, physiotherapy and therapeutic physical education. 2011; 2: 27-30.
Gyawali C.P., Carlson D.A., Chen J.W., Patel A. et al. ACG Clinical guidelines: clinical use of esophageal physiologic testing. Am. J. Gastroenterol. 2020; 115(9): 1412–28.
Gyawali C.P., Fass R. Management of gastroesophageal reflux disease. Gastroenterology. 2018; 154(2): 302–18.
Savarino V., Marabotto E., Zentilin P., Furnari M. et.al. Pathophysiology, diagnosis, and pharmacological treatment of gastro- esophageal reflux disease. Expert Rev. Clin. Pharmacol. 2020;
Tsukanov V.V., Kasparov E.V., Tonkikh J.L., Shtygasheva O.V. et al. Peptic ulcer disease and Helicobacter pylori infection in different Siberian ethnicities. Helicobacter. 2017;
Kalyagin A.N. Atypical extraesophageal manifestations of gastroesophageal reflux disease // Gastroesophageal reflux disease: Proceedings of the conference for physicians, which took place in the international exhibition “Siberian Healthcare-2004” / Ed. A.N. Kalyagin. – Irkutsk, 2004. – P.14-23
Carlsson R., Dent J., Bolling-Sternevald E. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. // Scand J Gastroenterol. – 1998.
Bordin D.S., Kolbasnikov S.V., Kononova A.G. The importance of alginates in the diagnosis and treatment of gastroesophageal reflux disease. Russian Medical Journal. 2014; (15): 1108-11.
Maev I.V., Kazyulin A.N., Busarova G.A. and others. Features of nitric oxide metabolism in gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2006; (5): 8-11.
The insidiousness of gastroesophageal reflux disease (ed. article). District doctor. 2015: (1): 50-2 (Ukraine).
Trukhmanov A.S. Barrett's esophagus: epidemiology, pathogenesis, clinical course, prevention. Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2002; (5): 59-62. 11.
Simanenkov V.I., Tikhonov S.V. Supportive treatment in patients with gastroesophageal reflux disease. Pharmaceutical library. 2014; (2): 54-60.
Ilyashevich I.G., Konovalova N. V., Tikhonov S. V. Non-systemic manifestations of gastroesophageal reflux disease. Volume 5, No. 1, 2013.
Onuchina E., Brikov S., Tsukanov V. Extraesophageal manifestations and their early symptomatic therapy in elderly patients with gastroesophageal reflux disease. Doctor 2014; 3:73-76.
Lyamina S.V., Mayev I. V., Kladovikova O. V., Malyshev I. Yu. Cellular and molecular mechanisms of inflammation of the esophageal mucosa in various clinical course of gastroesophageal reflux disease and its complications. Therapeutic Archive 2018; 02: 79-84
Komissarenko I.A., Levchenko S. V., Mikheeva O. M. The use of proton pump inhibitors in patients with gastroesophageal reflux disease on the background of coronary heart disease. Consilium Medicum. 2015; 17 (8): 15–19.
